Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study (Q37135912)

18 August 2017

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study (English)

1 reference

18 August 2017

1 reference

cervix uterine cancer

1 reference

7

Silvia de Sanjose

0 references

Matejka Rebolj

Marjolein van Ballegooijen

2

object named as

Matejka Rebolj

0 references

12

object named as

Marjolein van Ballegooijen

1 reference

18 August 2017

1

Joakim Dillner

1 reference

18 August 2017

5

Anne Szarewski

1 reference

18 August 2017

9

Belen Lloveras

1 reference

18 August 2017

11

Jack Cuzick

1 reference

18 August 2017

3

Philippe Birembaut

1 reference

18 August 2017

Matejka Rebolj

2

1 reference

18 August 2017

Karl-Ulrich Petry

4

1 reference

18 August 2017

Christian Munk

6

1 reference

18 August 2017

Silvia de Sanjose

7

1 reference

18 August 2017

Pontus Naucler

8

1 reference

18 August 2017

Susanne Kjaer

10

1 reference

18 August 2017

Christine Clavel

13

1 reference

18 August 2017

Thomas Iftner

14

1 reference

18 August 2017

Joint European Cohort Study

15

1 reference

18 August 2017

language of work or name

English

0 references

publication date

13 October 2008

1 reference

18 August 2017

1 reference

18 August 2017

337

1 reference

18 August 2017

a1754

1 reference

Human papillomavirus and Papanicolaou tests to screen for cervical cancer

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658827

Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658827

HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658827

Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658827

Long-term protective effect of high-risk human papillomavirus testing in population-based cervical screening

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658827

Cervical cancer screening programmes and policies in 18 European countries

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658827

Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658827

Cervical human papillomavirus infection in the female population in Barcelona, Spain

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658827

Chapter 13: Primary screening of cervical cancer with human papillomavirus tests

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658827

Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658827

Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658827

Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658827

Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658827

Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658827

Population-based study of screening test performance indices of three human papillomavirus DNA tests

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658827

Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology-Results from the Hammersmith study.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658827

Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658827

Colposcopic and histopathologic evaluation of women participating in population-based screening for human papillomavirus deoxyribonucleic acid persistence.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658827

Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658827

Human papillomavirus DNA testing by PCR-ELISA and hybrid capture II from a single cytological specimen: concordance and correlation with cytological results

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658827

Overview of the European and North American studies on HPV testing in primary cervical cancer screening

20 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658827

Trends in Cervical Squamous Cell Carcinoma Incidence in 13 European Countries: Changing Risk and the Effects of Screening

4 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658827

Estimates of cancer incidence and mortality in Europe in 1995

4 December 2018

1 reference

12 December 2020

Validity of prognostic models: when is a model clinically useful?

1 reference

12 December 2020

Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial

1 reference

12 December 2020

Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial

1 reference

12 December 2020

Cumulative 5-year diagnoses of CIN2, CIN3 or cervical cancer after concurrent high-risk HPV and cytology testing in a primary screening setting

1 reference

12 December 2020

Inflation of Sensitivity of Cervical Cancer Screening Tests Secondary to Correlated Error in Colposcopy

1 reference

12 December 2020

Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.A1754

1 reference

18 August 2017

1 reference

18 August 2017

1 reference